These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 19922891)
1. Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a Phase I-II, open-label trial. Vollmer T; Henney HR Clin Ther; 2009 Oct; 31(10):2206-14. PubMed ID: 19922891 [TBL] [Abstract][Full Text] [Related]
2. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study. Vollmer T; Blight AR; Henney HR Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892 [TBL] [Abstract][Full Text] [Related]
3. Sustained-release fampridine for symptomatic treatment of multiple sclerosis. Korenke AR; Rivey MP; Allington DR Ann Pharmacother; 2008 Oct; 42(10):1458-65. PubMed ID: 18780812 [TBL] [Abstract][Full Text] [Related]
4. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals. March B; Cardi T Expert Opin Investig Drugs; 2009 Dec; 18(12):1807-15. PubMed ID: 19938897 [TBL] [Abstract][Full Text] [Related]
6. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study. Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study. Zhao RK; Cheng G; Tang J; Song J; Peng WX Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896 [TBL] [Abstract][Full Text] [Related]
10. Single-Dose pharmacokinetics of sustained-release fampridine (Fampridine-SR) in healthy volunteers and adults with renal impairment. Smith W; Swan S; Marbury T; Henney H J Clin Pharmacol; 2010 Feb; 50(2):151-9. PubMed ID: 19966074 [TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers. Vaughan D; Speed J; Medve R; Andrews JS Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420 [TBL] [Abstract][Full Text] [Related]
13. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [TBL] [Abstract][Full Text] [Related]
14. The safety profile of dalfampridine extended release in multiple sclerosis clinical trials. Cornblath DR; Bienen EJ; Blight AR Clin Ther; 2012 May; 34(5):1056-69. PubMed ID: 22497693 [TBL] [Abstract][Full Text] [Related]
15. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M; Tempero K; Kirby M; Thompson J Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers. Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136 [TBL] [Abstract][Full Text] [Related]
18. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers. Blight AR; Henney HR Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]